A method of inhibiting platelet dependent arterial thrombosis in a patient which method comprises administering to said patient a therapeutically effective amount of peptide represented by Formula 1 ##STR1## wherein Z is hydrogen or a C1 -C6 acyl; X is a halogen atom; and the hydrohalic acid addition products thereof.